Search

PythonReactSEOPDF
OpenClaw

admet-prediction

ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction for drug candidates. Use for assessing drug-likeness, PK properties, and safety risks early in drug discovery. Keywords: ADMET, PK, toxicity, drug-likeness, DILI, hERG, bioavailability

huifer0 source installs☆ 0 Repository starsv1.0.0

Installation

Follow the repository instructions for this skill and your agent. Review the files and dependencies before adding it to your workflow.

SkillHub CLI

skillhub install huifer/admet-prediction

Inspect the source and compatibility requirements, then follow its installation steps.

Give your agent the source link and ask it to inspect instructions and dependencies before explaining the installation steps.

View source ↗Guides

Skill instructions

ADMET Prediction Skill

Predict ADMET properties to prioritize compounds for development.

Quick Start

/admet "CC1=CC=C(C=C1)CNC" --full
/pk-prediction --library compounds.sdf --threshold 0.7
/toxicity-screen CHEMBL210 --include hERG,DILI,Ames

What's Included

Property Prediction Model
Absorption Caco-2, HIA, Pgp ML/QSAR
Distribution VDss, PPB, BBB ML/QSAR
Metabolism CYP inhibition, clearance ML/QSAR
Excretion Clearance, half-life ML/QSAR
Toxicity hERG, DILI, Ames, mutagenicity ML/QSAR

Output Structure

# ADMET Profile: CHEMBL210 (Osimertinib)

## Summary
| Property | Value | Status |
|----------|-------|--------|
| Drug-likeness | Pass | ✓ |
| Lipinski Ro5 | 0 violations | ✓ |
| VEBER | Pass | ✓ |
| PAINS | 0 alerts | ✓ |
| Brenk | 0 alerts | ✓ |

## Absorption
| Property | Prediction | Confidence |
|----------|------------|-------------|
| HIA | 98% | High |
| Caco-2 | 15.2 × 10⁻⁶ cm/s | High |
| Pgp substrate | Yes | Medium |
| F30% | 65% | Medium |

## Distribution
| Property | Prediction | Confidence |
|----------|------------|-------------|
| VDss | 5.2 L/kg | Medium |
| PPB | 95% | High |
| BBB | Yes | High |
| CNS MPO | 5.5 | Good |

## Metabolism
| Property | Prediction | Confidence |
|----------|------------|-------------|
| CYP3A4 substrate | Yes | High |
| CYP3A4 inhibitor | Yes | Medium |
| CYP2D6 inhibitor | No | High |
| CYP2C9 inhibitor | No | Medium |
| Clearance | 8.5 mL/min/kg | Low |

## Excretion
| Property | Prediction | Confidence |
|----------|------------|-------------|
| Renal clearance | 10% | Medium |
| Half-life | 48 hours | High |

## Toxicity
| Property | Prediction | Confidence |
|----------|------------|-------------|
| hERG inhibition | No | High |
| DILI | Concern | Medium |
| Ames mutagenicity | Negative | High |
| Carcinogenicity | Negative | Medium |
| Respiratory toxicity | No | Low |

## Recommendations
**Strengt...

Source information

Source
github
Repository
openclaw/skills
Path
skills/huifer/admet-prediction
Version
1.0.0
Commit
4980dcd6e6d1e44370778e8128df1689af30afc5
Classification source
rules
Status
active
Visibility
public

These signals come from indexed source analysis and may lag behind changes. Check the current source files.

Extracted content

SKILL.md
# ADMET Prediction Skill

Predict ADMET properties to prioritize compounds for development.

## Quick Start

```
/admet "CC1=CC=C(C=C1)CNC" --full
/pk-prediction --library compounds.sdf --threshold 0.7
/toxicity-screen CHEMBL210 --include hERG,DILI,Ames
```

## What's Included

| Property | Prediction | Model |
|----------|------------|-------|
| Absorption | Caco-2, HIA, Pgp | ML/QSAR |
| Distribution | VDss, PPB, BBB | ML/QSAR |
| Metabolism | CYP inhibition, clearance | ML/QSAR |
| Excretion | Clearance, half-life | ML/QSAR |
| Toxicity | hERG, DILI, Ames, mutagenicity | ML/QSAR |

## Output Structure

```markdown
# ADMET Profile: CHEMBL210 (Osimertinib)

## Summary
| Property | Value | Status |
|----------|-------|--------|
| Drug-likeness | Pass | ✓ |
| Lipinski Ro5 | 0 violations | ✓ |
| VEBER | Pass | ✓ |
| PAINS | 0 alerts | ✓ |
| Brenk | 0 alerts | ✓ |

## Absorption
| Property | Prediction | Confidence |
|----------|------------|-------------|
| HIA | 98% | High |
| Caco-2 | 15.2 × 10⁻⁶ cm/s | High |
| Pgp substrate | Yes | Medium |
| F30% | 65% | Medium |

## Distribution
| Property | Prediction | Confidence |
|----------|------------|-------------|
| VDss | 5.2 L/kg | Medium |
| PPB | 95% | High |
| BBB | Yes | High |
| CNS MPO | 5.5 | Good |

## Metabolism
| Property | Prediction | Confidence |
|----------|------------|-------------|
| CYP3A4 substrate | Yes | High |
| CYP3A4 inhibitor | Yes | Medium |
| CYP2D6 inhibitor | No | High |
| CYP2C9 inhibitor | No | Medium |
| Clearance | 8.5 mL/min/kg | Low |

## Excretion
| Property | Prediction | Confidence |
|----------|------------|-------------|
| Renal clearance | 10% | Medium |
| Half-life | 48 hours | High |

## Toxicity
| Property | Prediction | Confidence |
|----------|------------|-------------|
| hERG inhibition | No | High |
| DILI | Concern | Medium |
| Ames mutagenicity | Negative | High |
| Carcinogenicity | Negative | Medium |
| Respiratory toxicity | No | Low |

## Recommendations
**Strengt...

Related skills

OpenClaw

13-Day Sprint Method

galizki

Productivity system based on Maya calendar with 13 natural tones for project management and personal development

OpenClaw

1password

daggerkun007

Set up and use 1Password CLI (op). Use when installing the CLI, enabling desktop app integration, signing in (single or multi-account), or reading/injecting/running secrets via op.